L C Hwang1, S Fein, H Levitsky
1Department of Medical Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
New prostate cancer immunotherapy trials are exploring advanced vaccines and cell-based strategies. Understanding antitumor immunity and tumor antigens will refine these potent treatments for future clinical use.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: